Llwytho...
Impact of disease‐modifying drugs on the severity of COVID‐19 infection in multiple sclerosis patients
Recent evidence suggested that neurological manifestations occur in patients with a severe form of coronavirus disease (COVID‐19). On the basis of this issue, neurologists are very concerned about patients with neurological disorders, especially multiple sclerosis (MS), as consumers of immunosuppres...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Med Virol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675642/ https://ncbi.nlm.nih.gov/pubmed/33044760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26593 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|